Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-23

Clinical Trial Update: Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the combination of clofarabine and temsirolimus in older patients with relapsed or refractory acute myeloid leukemia;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clofarabine (clofarabine)
  • Temsirolimus (temsirolimus)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2015-03-23